Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals Plc

47.75
USD
+0.67
(+1.41%)
4.33BMarket Cap
Feb 25Next Earn

Total Valuation

USD

As of June 30, 2026, Hikma Pharmaceuticals plc. carries a market capitalization of 4.33B, placing it among publicly traded companies globally. Its enterprise value stands at 6.02B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap4.33B
Enterprise Value6.02B

Important Dates

Hikma Pharmaceuticals plc.'s next confirmed earnings release is scheduled for February 25, 2027.

Earnings Date2/25/2027

Share Statistics

As of June 30, 2026, Hikma Pharmaceuticals plc. has 105.11M shares outstanding.

Shares Outstanding105.11M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio1.72
P/TBV Ratio3.11

Financial Position

As of June 30, 2026, Hikma Pharmaceuticals plc. maintains a current ratio of 1.98, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

Current Ratio1.98
Quick Ratio0.21
Debt / Equity77.11

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count9,400.00

Stock Price Statistics

USD

As of the close on November 4, 2026, Hikma Pharmaceuticals plc.'s stock has gained approximately 1.17% over the past 52 weeks. The 50-day moving average sits at 42.71, while the 200-day moving average is 42.80.

52-Week Price Change1.17%
50-Day Moving Average42.71
200-Day Moving Average42.80

Balance Sheet

USD

As of June 30, 2026, Hikma Pharmaceuticals plc. holds 289.00M in cash and equivalents against 1.96B in total debt, resulting in a net debt position of 1.61B. Total book value stands at 2.52B, with working capital of 1.36B providing operational flexibility.

Cash & Cash Equivalents289.00M
Total Debt1.96B
Net Debt1.61B
Equity (Book Value)2.52B
Book Value Per Share24.00
Working Capital1.36B